May 18, 2022

Mozart Therapeutics to Present on Novel CD8 T Cell Network at the 2022 Digestive Disease Week^® (DDW) Conference

May 10, 2022

Mozart Therapeutics Presents Data at IMMUNOLOGY^™ 2022 Highlighting Novel CD8 Treg Network in Celiac Disease and Other Autoimmune Diseases

March 21, 2022

Mozart Therapeutics Announces Appointment of Jan Beck as Chief Operating Officer

October 26, 2021

Mozart Therapeutics Launches with $55 Million Series A Financing to Develop Disease Modifying Therapeutics for Autoimmune and Inflammatory Diseases